Literature DB >> 8373706

Do diuretics cause magnesium deficiency?

D L Davies1, R Fraser.   

Abstract

1. Controlled trials, of which there are few, do not substantiate claims that diuretics play a role in causing magnesium deficiency. Consequently, the vast majority of patients taking conventional doses of thiazide diuretics (i.e. bendrofluazide 2.5 mg day-1 or equivalent) do not need magnesium supplements. On balance, potassium-sparing diuretics tend to increase serum and intracellular magnesium content; this should not be taken as evidence of prior magnesium deficiency. It remains theoretically possible that large doses of loop diuretics given more than once daily for long periods could induce negative magnesium balance and magnesium deficiency. However, it has been difficult to run appropriately controlled trials in conditions where such therapy is needed (i.e. heart failure) and until more reliable information becomes available no absolute recommendation can be made. 2. Methods for the measurement of intracellular free magnesium levels are now available and are more relevant to the assessment of magnesium deficiency than total intracellular magnesium content; the complex relationship between intracellular free and total magnesium content remains to be defined. Future work involving the effect of diuretics on intracellular free magnesium measurements should make every attempt to avoid the errors of trial design and multiple publication that litter current and past literature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373706      PMCID: PMC1364546          DOI: 10.1111/j.1365-2125.1993.tb05883.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  122 in total

1.  Effects of the thiazide diuretic bendroflumethiazide on salivary flow rate and composition.

Authors:  T Nederfors; S Twetman; C Dahlöf
Journal:  Scand J Dent Res       Date:  1989-12

2.  [Action of trichlormethiazide and amiloride on cellular Na+, K+ and Mg+ concentrations].

Authors:  K Kisters; W Zidek; K H Rahn
Journal:  Schweiz Med Wochenschr       Date:  1989-12-16

3.  Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects.

Authors:  W P Leary; A J Reyes; R D Wynne; K van der Byl
Journal:  J Int Med Res       Date:  1990 Mar-Apr       Impact factor: 1.671

4.  Is hypomagnesemia or magnesium deficiency arrhythmogenic?

Authors:  B Surawicz
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

5.  Effects of diuretic therapy and exercise-related arrhythmias in systemic hypertension.

Authors:  V Papademetriou; A Notargiacomo; D Heine; R D Fletcher; E D Freis
Journal:  Am J Cardiol       Date:  1989-11-15       Impact factor: 2.778

6.  Magnesium deficiency in two hypertensive patient groups.

Authors:  C B Seelig
Journal:  South Med J       Date:  1990-07       Impact factor: 0.954

Review 7.  Effects of magnesium on skeletal metabolism.

Authors:  S Wallach
Journal:  Magnes Trace Elem       Date:  1990

8.  [Hypotensive and metabolic effects of small doses of hydrochlorothiazide in the long-term treatment of elderly patients with systolic arterial hypertension].

Authors:  B Halawa
Journal:  Wiad Lek       Date:  1989-02-15

Review 9.  Clinical intervention studies on magnesium in myocardial infarction.

Authors:  H S Rasmussen
Journal:  Magnesium       Date:  1989

10.  Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure.

Authors:  M A Ralston; M R Murnane; R E Kelley; R A Altschuld; D V Unverferth; C V Leier
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

View more
  5 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.

Authors:  N Cohen; D Almoznino-Sarafian; R Zaidenstein; I Alon; O Gorelik; M Shteinshnaider; S Chachashvily; Z Averbukh; A Golik; Z Chen-Levy; D Modai
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

3.  Increased expression of renal TRPM6 compensates for Mg(2+) wasting during furosemide treatment.

Authors:  Annelies A van Angelen; AnneMiete W van der Kemp; Joost G Hoenderop; René J Bindels
Journal:  Clin Kidney J       Date:  2012-11-07

Review 4.  Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.

Authors:  Emily S Mohn; Hua J Kern; Edward Saltzman; Susan H Mitmesser; Diane L McKay
Journal:  Pharmaceutics       Date:  2018-03-20       Impact factor: 6.321

5.  Renal sodium and magnesium reabsorption are not coupled in a mouse model of Gordon syndrome.

Authors:  Wouter H van Megen; Paul R Grimm; Paul A Welling; Jenny van der Wijst
Journal:  Physiol Rep       Date:  2018-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.